Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
Clinical trial NCT01976338 · COMPLETED
Trial details
- NCT number
- NCT01976338
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-12
- Primary completion
- 2016-03-28
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.